UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report: ~~May~~June 416, 2022

(Date of earliest event reported)

QUANTA, INC.

(Exact name of registrant as specified in its charter)

Nevada		000-56025		81-2749032
(State of Incorporation)		Commission File Number		(IRS EIN)

632 S Glenwood Place

Burbank, CA 91506

(Address of principal executive offices)

(818) 659-8052

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered.

Common Stock

QNTA

OTCQB

Item 7 1.01 ~~Regulation~~Entry FDinto ~~Disclosure~~a Material Definitive Agreement

On ~~May~~November 412, ~~2022~~2021, Quanta, Inc., a Nevada corporation (the “Company”), ~~issued~~entered ainto ~~press release announcing that it will hold~~ a ~~conference~~Securities ~~call~~Purchase onAgreement ~~Thursday,~~(the ~~May~~“Purchase ~~12,~~Agreement”) ~~2022~~with atTrillium ~~5:00~~Partners, ~~PM Eastern Standard Time~~L. ~~During the call~~P., ~~the~~a ~~Company’s~~Delaware ~~CEO,~~limited ~~Dr.~~partnership ~~Arthur~~(the ~~Mikaelian~~“Investor”) pursuant Heto ~~will~~which ~~present on~~ the ~~Company’s~~Investor ~~recently~~purchased ~~achieved~~a ~~milestones,~~convertible asnote ~~well~~in as the ~~future~~principal ~~positioning~~amount of $82,500 (the ~~Company.~~“Note”) ~~Interested~~and ~~parties~~a Warrant ~~may~~to ~~register for~~purchase ~~the~~Common ~~call~~Stock ~~via~~of the ~~following~~Company ~~website: https://us06web.zoom.us/webinar/register/WN_oPsR6XT3QOyuze3yp-eZyQ. Additionally, questions may be submitted~~ in ~~advance~~favor byof ~~sending~~Investor anexercisable ~~email~~into ~~prior to 12:00 PM Eastern Standard Time on Wednesday~~8, ~~May 11~~250,000 ~~2022~~shares toof ~~ir@medoliferx.com~~Common ~~with ‘QNTA~~Stock ~~Question’ in~~ (the ~~subject line~~“Warrant”).

The ~~press~~Note ~~release~~accrues isinterest ~~attached~~at ~~hereto~~a asrate anof ~~exhibit~~12% per annum from the Issue Date and has a Maturity Date of November 12, 2022. The Investor is ~~incorporated~~entitled to, at its option, convert all or any the principal amount and any accrued but unpaid interest of the Note into shares of the Company’s Common Stock at a conversion price of $0.01 per share. The Investor has contractually agreed to limit its conversion right so that no conversion may be made that would result in beneficial ownership by ~~reference~~the ~~herein~~Investor and/or its affiliates of more than 4.999% of the outstanding shares of Common Stock of the Company.

The Warrant is exercisable at a price per share equal to $0.01. The Warrant may also be exercised via cashless exercise by surrendering the Warrant for the number of shares of Common Stock determined by multiplying the number of Warrant Shares to which it would otherwise be entitled by a fraction, the numerator of which shall be the difference between the then current Market Price per share of the Common Stock and the Exercise Price, and the denominator of which shall be the then current Market Price per share of Common Stock.

The foregoing descriptions of the Purchase Agreement, the Note, and the Warrant do not purport to be complete and are qualified in their entirety by reference to the full text of the Purchase Agreement, the Note, and the Warrant, the forms of which are filed as Exhibits 10.1, 10.2, and 10.3, hereto.

Item 9.01

Exhibits.

Exhibit No.		Description
99.1		Press Release Dated May 4, 2022
10.1		Securities Purchase Agreement between the Company and Trillium Partners L.P. dated November 12, 2021
10.2		Convertible Promissory Note issued to Trillium Partners L.P. dated November 12, 2021
10.3		Common Stock Purchase Warrant issued to Trillium Partners L.P. dated November 12, 2021
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	Quanta, Inc.
Dated: May 4, 2022	By:	/s/ Arthur Mikaelian
Dated: June 16, 2022
	By:	/s/ Arthur Mikaelian
		Arthur Mikaelian, CEO

Filing Compare · QUANTA INC